We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 25,177

High Court date set: to patent or not to patent isolated DNA?
  • Watermark Patent & Trade Marks Attorneys
  • Australia
  • May 29 2015

The date is set. The High Court of Australia will begin proceedings on 16 June 2015 to ultimately decide the patentability of isolated genetic


Two cases of CCPIT Patent and Trademark Law Office being elected the “Top 10 Reexamination and Invalidation cases in 2014”
  • CCPIT Patent & Trademark Law Office
  • China
  • May 29 2015

During the Intellectual Property Promotion Week of 2015, the Patent Reexamination Board of the State Intellectual Property Office published the "Top


Using declarations to invoke AIA first-inventor-to-file exceptions
  • Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • USA
  • May 28 2015

This chart illustrates how to use declarations under 37 C.F.R. 1.130 to invoke an exception to 35 U.S.C. 102(a) and have a reference disqualified


Italy ready to embrace the unitary patent
  • Marks & Clerk
  • European Union
  • May 28 2015

Following the recent decision of the Court of Justice of the European Union dismissing the Spanish challenge to the legality of the EU laws enacted


Last month at the Federal Circuit - May 2015
  • Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • USA
  • May 28 2015

In Intellectual Ventures II LLC v. JPMorgan Chase & Co., No. 14-1724 (Fed. Cir. Apr. 1, 2015), the Federal Circuit dismissed an interlocutory appeal


Podcast: Daniel Cooley and Joshua Goldberg on the USPTO updates to the Rules of Practice for Trials before the PTAB
  • Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • USA
  • May 28 2015

On May 19, 2015, the United States Patent & Trademark Office made several "ministerial" changes to the rules governing Patent Trial and Appeal Board


Update on patenting medical uses in Canada
  • Marks & Clerk
  • Canada
  • May 28 2015

On 18 March 2015, the Canadian Intellectual Property Office (CIPO) issued revised examination guidelines on medical use claims, the complete text of


Publication date on non-patent literature found to meet exception to hearsay rule in Final Written Decision for IPR2014-00527
  • Drinker Biddle & Reath LLP
  • USA
  • May 28 2015

The assignment of a publication date in the copyright line of an IEEE publication has equivalent circumstantial guarantees of trustworthiness as with


Granting Motion for Additional Discovery IPR2014-01005
  • Drinker Biddle & Reath LLP
  • USA
  • May 28 2015

The movant is not always required to show a nexus between the additional discovery and the claims of the patent at issue when moving for additional


Denying institution because of insufficient explanation of why posita would have found the invention obvious IPR2015-00167
  • Drinker Biddle & Reath LLP
  • USA
  • May 28 2015

A declaration that alleges a particular feature would have been obvious to an ordinary artisan but fails to provide sufficient explanation for why it